Filter announcements
Loading...
It is a digital-first, life sciences commercialization company. It helps biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way.
Indegene Limited has informed the Exchange about Amalgamation/Merger of Indirect Wholly Owned Subsidiaries of the Company in Germany
Indegene Limited has announced an in-person one-on-one meeting with Premji Invest in Bengaluru. The purpose of the interaction is to discuss company operations and business updates with investors and analysts, ensuring no unpublished price-sensitive information is shared during the session.
Indegene Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Indegene Limited officials are scheduled to hold 1x1 investor/analyst meetings on August 24-25, 2026. Participants include MFS International Singapore, ASK Investment Managers, Mirae Mutual Fund (online), Goldman Sachs Asset Management (in-person, Bengaluru), and Seven Canyon Advisors (online). No unpublished price sensitive information will be shared.
Indegene Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company